G. Stephen Noell
Pfizer (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Pharmacogenetics and Drug Metabolism, RNA Interference and Gene Delivery, Computational Drug Discovery Methods, Microbial Natural Products and Biosynthesis
Most-Cited Works
- → Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor(2014)180 cited
- → Targeted Delivery of DNA Using YEE(GalNAcAH)3, a Synthetic Glycopeptide Ligand for the Asialoglycoprotein Receptor(1994)94 cited
- → Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase(2017)76 cited
- → Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1(2013)66 cited
- → Autoantibodies to topoisomerase I (Scl-70): Analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay(1990)49 cited
- → Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold(2014)28 cited
- → CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus(1995)23 cited
- → Liver toxicity of a new anabolic agent: Methyltrienolone (17α-Methyl-4,9,11-estratriene-17β-ol-3-one)(1966)14 cited
- → STEROIDSTRUKTUR UND LEBERTOXIZITÄT(1967)11 cited
- → Zur Frage der altersbedingten Veränderungen der Larynxschleimhaut(1962)8 cited